Evidence map›Paper›PMID 40989790›Full record

ArticleERJ open research2025

Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures.

Toru Shirahata, Pietro Nardelli, Sirus Jesudasen, Ruben San José Estépar, Ariel H Curiale, Badar Patel, Eileen Harder, Rajan Saggar, Aaron B Waxman, Rebecca R Vanderpool and 4 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Toru ShirahataApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-8975-6618
Pietro NardelliApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sirus JesudasenDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ruben San José EstéparApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-7095-2432
Ariel H CurialeApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Badar PatelDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Eileen HarderDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rajan SaggarDivision of Pulmonary, Critical Care Medicine, Clinical Immunology, and Allergy, Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, CA, USA.
Aaron B WaxmanCenter for Pulmonary Heart Disease, Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0001-7797-0361
Rebecca R VanderpoolDivision of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.ORCID https://orcid.org/0000-0001-6038-0568
George R WashkoApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sydney B MontesiDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Raúl San José EstéparApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-3677-1996
Farbod N RahaghiApplied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

Vascular Leak and Outcomes in IPFK23HL150331 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MONTESI, SYDNEY · 2020 to 2024
$887k
Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial IntelligenceK25HL157601 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Pietro Nardelli · 2024 to 2026
$563k
Assessment of microvascular volume in smokers using AIR21HL177703 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Pietro Nardelli · 2025 to 2026
$269k
NHLBI NIH HHS K23 HL150331NHLBI NIH HHS K25 HL157601NHLBI NIH HHS R21 HL177703
6 · The paper itself

Abstract

Objectives: Since pulmonary hypertension (PH) worsens the prognosis of idiopathic pulmonary fibrosis (IPF), early prediction of PH is crucial for timely intervention. This study aims to develop and validate a machine learning model to predict PH using automated computed tomography (CT)-based 3D measurements, particularly central cardiovascular structures, segmented by a publicly available tool. Methods: We retrospectively studied 163 IPF patients who underwent both thin-section chest CT (contrast-enhanced and non-contrast) and right heart catheterisation within 2 years (78.5% within 6 months). Central CT structures were segmented using the TotalSegmentator Neural Network Version 1. We also manually measured pulmonary artery (PA) and ascending aorta (A) diameters. Random forest (RF) and logistic regression (LR) models were created and the model's reliability was assessed with 10-fold cross-validation. Shapley additive explanation (SHAP) analysis was performed to understand the contribution of each variable to the RF model. Results: Of the 163 patients, 75 had PH (46.0%). Significant differences were found in race, body mass index, right atrial (RA) volume, and PA volume between PH and non-PH patients. The RF model outperformed the LR model, showing higher area under the curve (AUC) (0.87 Conclusion: The RF model with volumetric measures showed superior predictive performance for PH. Notably, both the RF model and segmentations of central CT structures are automated, facilitating seamless integration into clinical practice.

Identifiers

PMID40989790
PMCPMC12451577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.